As an early entrant in the market, eFoodSafety recognizes potential to use its Citroxin formula in the mass market as a solution against the virulent influenza. After positive initial results for Citroxin’s ability to eradicate H5N1 in chick embryos, eFoodSafety has planned to conduct additional rounds of testing in live animals affected with forms of flu that closely resemble human strains of the disease. The company’s initial tests were conducted at Chulalongkorn University in Thailand, one of only two labs in Asia that is used by the U.S. Centers of Disease Control to conduct research on treatments of H5N1. Subsequent rounds of testing are planned by the company to be conducted at a university in the United States that has been nationally recognized for its field studies in bird flu.